| Patents for C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637) |
|---|
| 04/16/2009 | CA2702103A1 Improvements in or relating to amphotaric liposomes comprising neutral lipids |
| 04/15/2009 | EP1311532B1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 04/08/2009 | EP2044100A2 Sulphonylaminocarbonyl derivatives of bile acid amides for use as immunomodulators |
| 04/01/2009 | CN101400690A Modulators of hypoxia inducible factor-1 and related uses |
| 03/25/2009 | EP2039702A2 Prodrugs erbeta-selective substances, method for their production and pharmaceutical compounds containing these compositions |
| 03/25/2009 | EP2039701A2 20-keto-11beta-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 03/25/2009 | CN101395170A Bile acid derivatives as FXR ligands for the prevention or treatment of FXR-mediated diseases or conditions |
| 03/24/2009 | US7507725 Compounds with sulphonamide group and pharmaceutical compositions containing these compounds |
| 03/19/2009 | WO2009033505A1 Hellebrin derivatives |
| 03/19/2009 | WO2009001148A3 INDUSTRIAL METHOD FOR THE SYNTHESIS OF 17-ACETOXY-11β-[4-(DIMETHYLAMINO)-PHENYL]-21-METHOXY-19-NORPREGNA-4,9-DIEN-3,20-DIONE AND THE KEY INTERMEDIATES OF THE PROCESS |
| 03/19/2009 | WO2008155141A3 Novel facultative catonic sterols |
| 03/12/2009 | WO2008151746A3 17β-CYANO-19-NOR-ANDROST-4-ENE DERIVATIVE, USE THEREOF AND MEDICAMENTS CONTAINING SAID DERIVATIVE |
| 03/11/2009 | EP2033966A2 Movel photoacid generators, resist compositons, and patterning processes |
| 03/11/2009 | EP2033965A2 17-alpha-substituted-11-beta-substituted-4-aryl and 21-substituted 19-norpregnadienedione as antiprogestational agents |
| 03/11/2009 | EP2033948A1 Process for preparing Estrogen-antagonistic 11beta-Fluoro-17alpha-alkylestra-1,3,5 (10)-triene-3, 17-diols having a 7alpha-(xi-Alkylamino-omega-perfluoroalkyl)alkyl side chain and alpha-Alkyl(amino)-omega-perfluoro(alkyl)alkanes and processes for their preparation |
| 03/10/2009 | US7501403 Bile acid or bile salt fatty acid conjugates |
| 03/05/2009 | WO2009027994A2 NOVEL STEROIDAL ESTERS OF 17-OXIMINO-5-ANDROSTEN-3β-OL |
| 03/05/2009 | WO2009027108A1 PROCESS FOR PREPARING ESTROGEN-ANTAGONISTIC 11 β-FLUORO-17α-ALKYLESTRA-1,3,5(10)-TRIENE-3,17-DIOLS HAVING A 7α-(ξ-ALKYLAMINO-ω-PERFLUOROALKYL)ALKYL SIDE CHAIN AND α-ALKYL(AMINO)-ω-PERFLUORO(ALKYL)ALKANES AND PROCESSES FOR THEIR PREPARATION |
| 03/05/2009 | WO2008088935A3 Pharmaceutically acceptable salts of 11- (4-aminophenyl) -19-n0rpregna-4,9 (10) -diene-3, 20-dione derivatives |
| 03/05/2009 | CA2697713A1 Process for preparing estrogen-antagonistic 11 .beta.-fluoro-17.alpha.-alkylestra-1,3,5(10)-triene-3,17-diols having a 7.alpha.-(.xi.-alkylamino-.omega.-perfluoroalkyl)alkyl side chain and .alpha.-alkyl(amino)-.omega.-perfluoro(alkyl)alkanes and processes for their preparation |
| 02/26/2009 | WO2009024022A1 Fatty acid bile acid conjugates and medical uses thereof |
| 02/25/2009 | EP2027141A1 11beta-benzaldoxime derivatives of d-homooestra-4,9-dien-3-ones |
| 02/25/2009 | EP2027140A1 Industrial process for the synthesis of 17 alpha -acetoxy-11 beta -[4-(n,n-dimethyl-amino)- phenyl]-19-norpregna-4,9-diene-3,20-dione and new intermediates of the process |
| 02/25/2009 | CN101374854A Process for production of steroids |
| 02/24/2009 | CA2355888C Blood pool agents for nuclear magnetic resonance diagnostics |
| 02/12/2009 | CA2830727A1 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 02/12/2009 | CA2666246A1 Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 02/04/2009 | EP0821589B1 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 02/04/2009 | CN101360757A High purity 17alfa-cyanomethyl-17beta-hydroxy-estra-4,9-diene-3-one and process for the synthesis thereof |
| 02/03/2009 | CA2409869C Novel solid body forms of mesoprogestin 11.beta.-[4e-(hydroxyiminomethyl)-phenyl]-17.alpha.-methoxymethyl-17.beta.-methoxy-estra-4,9-dien-3-one |
| 01/28/2009 | EP2018858A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic trioxide |
| 01/22/2009 | US20090023896 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 01/21/2009 | EP1817325B1 Sulfated molecular umbrellas containing 6-200 cholanic acid (derivative) units as anti-hiv and anti-hsv agents |
| 01/21/2009 | CN100453549C 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
| 01/14/2009 | EP1497309B1 Aminoalkyl sterol compounds having an anti-tumoral and neuroprotective activity |
| 01/13/2009 | US7476727 Conjugates of mycophenolic acid |
| 01/07/2009 | EP2010555A2 Method for preparing 4-[17beta -methoxy-17 -alpha methoxymethyl-3-oxoestra-4,9-dien-11beta -yl]benzaldehyde (e)-oxime (asoprisnil) |
| 01/06/2009 | CA2412541C 9.alpha.-chloro-6.alpha.-fluoro-17.alpha.-hydroxy-16-methyl-17-.beta.-methoxycarbonyl-androst-1,4-dienes esterified in position 17.alpha. by a cyclic acyl group |
| 01/06/2009 | CA2339174C Aminosterol compounds and uses thereof |
| 12/31/2008 | CA2677195A1 Industrial method for the synthesis of 17-acetoxy-11.beta.-[4-(dimethylamino)-phenyl]-21-methoxy-19-norpregna-4,9-dien-3,20-dione and the key intermediates of the process |
| 12/24/2008 | WO2008155141A2 Novel facultative catonic sterols |
| 12/24/2008 | EP2004668A2 Amino derivatives of androstanes and androstenes as medicaments for cardiovascular disorders |
| 12/24/2008 | EP2004667A2 Novel 11 beta - hydroxyandrosta-4-ene-3-ones |
| 12/18/2008 | WO2008152112A2 17ß-CYANO-19-ANDROST-4-ENE DERIVATIVE, USE THEREOF AND MEDICAMENTS CONTAINING SAID DERIVATIVE |
| 12/18/2008 | WO2008151745A1 17beta-cyano-18a-homo-19-nor-androst-4-ene derivative, use thereof and medicaments containing said derivative |
| 12/18/2008 | DE102007027637A1 17ß-Cyano-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 17ß-cyano-19-nor-androst-4-ene derivative, its use and pharmaceutical compositions containing the derivative |
| 12/18/2008 | DE102007027636A1 17ß-Cyano-18a-homo-19-nor-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 17ß-cyano-18a-homo-19-nor-androst-4-ene derivative, the use of the derivative and pharmaceutical compositions containing them |
| 12/18/2008 | DE102007027635A1 17ß-Cyano-19-androst-4-en-Derivat, dessen Verwendung und das Derivat enthaltende Arzneimittel 17ß-cyano-19-androst-4-ene derivative, its use and pharmaceutical compositions containing the derivative |
| 12/18/2008 | CA2692997A1 17.beta.-cyano-19-androst-4-ene derivative, its use and medicaments comprising the derivative |
| 12/18/2008 | CA2690959A1 17.beta.-cyano-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative |
| 12/18/2008 | CA2689563A1 17.beta.-cyano-18a-homo-19-nor-androst-4-ene derivative, its use and medicaments comprising the derivative |
| 12/09/2008 | CA2462998C Novel estrogenic compounds |
| 12/04/2008 | WO2007134328A3 Geldanamycins and their quinone moieties inhibit cancer by acting on mitochondrial voltage-dependent anion channel (vdac) protein |
| 12/03/2008 | EP1383787B1 Sapogenin derivatives, their synthesis and use |
| 12/03/2008 | CN101316858A Sulfamoyl sulfonate prodrugs |
| 12/03/2008 | CN101316857A Prodrug ER-beta-selective substances, methods for the production thereof and pharmaceutical compositions containing said compounds |
| 12/03/2008 | CN101316856A Prodrugs of ER-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same |
| 12/03/2008 | CN101316814A Method for producing vitamin D derivative utilizing photoreaction |
| 11/27/2008 | WO2008090272A3 Novel method for the diastereoselective production of a chiral primary amine on a steroid |
| 11/20/2008 | WO2008078102A3 Lipids and their use as non-viral delivery vehicle |
| 11/18/2008 | CA2493704C Platinum complexes containing chemically modified bile acids, having antitumor activity |
| 11/06/2008 | WO2008134668A2 Heat-labile prodrugs |
| 11/06/2008 | WO2008067086A3 Compositions and methods for suppressing endometrial proliferation |
| 11/06/2008 | US20080275010 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
| 11/05/2008 | EP1987051A2 Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions |
| 11/05/2008 | CN101300265A Nitrooxy derivatives of glucocorticoids |
| 10/30/2008 | WO2008128844A1 Process for the preparation of tauroursodesoxycholic acid |
| 10/29/2008 | EP1985622A1 Process for the preparation of tauroursodesoxycholic acid |
| 10/28/2008 | CA2167321C Reagents and methods for the detection and quantification of testosterone in fluid samples |
| 10/23/2008 | WO2008124922A1 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
| 10/23/2008 | WO2008124878A1 Non-steroidal compounds |
| 10/23/2008 | CA2683522A1 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
| 10/22/2008 | CN101292162A Methods to identify therapeutic agents |
| 10/21/2008 | CA2205347C Lazaroids-based compositions and method for preventing adhesion formation using the same |
| 09/25/2008 | WO2008091540A3 23-substituted bile acids as tgr5 modulators and methods of use thereof |
| 09/25/2008 | US20080234242 angiogenesis inhibitor; antiinflammatory agents; immunosuppressants; steroids conjugated compound |
| 09/24/2008 | EP1971618A2 Modulators of hypoxia inducible factor-1 and related uses |
| 09/23/2008 | US7427610 e.g. 17 beta -Difluoromethyl-2-methoxy-estra-1,3,5(10)-trien-3-yl sulfamate; tubulin polymerization inhibitor; breast, prostate, colon, non-small-cell-lung cancer and primary dermal microvascular endothelial cell proliferation |
| 09/18/2008 | WO2008109936A1 Steroidal compounds |
| 09/16/2008 | CA2223910C Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (nhe), pharmaceutical methods and compositions employing such inhibitors, and processes for evaluating the nhe-inhibitory efficacy of compounds |
| 09/11/2008 | US20080221075 To treat obesity or diabetes; reduction of serum cholesterol and the treatment of atherosclerosis |
| 09/11/2008 | US20080221073 Nitrooxy Derivatives of Glucocorticoids |
| 09/11/2008 | US20080221070 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 09/10/2008 | CN101260136A Oestrogen derivatives as inhibitors of steroid sulphatase |
| 09/03/2008 | EP1963355A2 New cholest-4-en-3-one oxime derivatives, pharmaceutical compositions comprising them, and preparation process |
| 09/03/2008 | EP1963354A2 HIGH PURITY 17alfa-CYANOMETHYL-17beta-HYDROXY-ESTRA-4,9-DIENE-3-ONE AND PROCESS FOR THE SYNTHESIS THEREOF |
| 09/02/2008 | US7419780 invention relates to the evolution of enzymes in vivo, and drug screening in vivo through the use of chemical inducers of protein dimerization |
| 08/28/2008 | WO2008040792A3 Compositions comprising a sirna and lipidic 4,5-disubstituted 2-deoxystreptamine ring aminoglycoside derivatives and uses thereof |
| 08/27/2008 | EP1961740A1 Method for producing vitamin d derivative utilizing photoreaction |
| 08/27/2008 | EP1594886B1 Antitumoral d-homoestra-1, 3, 5 (10)-trien-3-yl 2-substituted sulfamates |
| 08/26/2008 | US7416744 Extracts, compounds and pharmaceutical compositions having anti-diabetic activity and their use |
| 08/26/2008 | CA2394731C Process for preparing 17alpha-acetoxy-11beta-[4-n,n-(dimethylamino)phenyl]-21-methoxy-19-norpregna-4,9-diene-3,20-dione, intermediates useful in the process, and processes for preparing such intermediates |
| 08/26/2008 | CA2333669C 17.beta.-amino and hydroxylamino-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 08/21/2008 | WO2008099414A1 NOVEL CATIONIC 17 α- SUBSTITUTED-ESTRADIOL DERIVATIVES USEFUL AS ANTI-CANCER AGENT |
| 08/20/2008 | EP1957515A2 PRODRUG ERbeta-SELECTIVE SUBSTANCES, METHODS FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 08/20/2008 | EP1957514A1 Prodrugs of er-beta-selective substances method for production thereof and pharmaceutical compositions comprising the same |
| 08/20/2008 | EP1957513A2 Sulfamoyl sulfonate prodrugs |
| 08/20/2008 | EP1836215B1 Androstane 17-alpha-carbonate for use in the treatment of inflammatory and allergic conditions |
| 08/19/2008 | US7414043 9-α-substituted estratrienes as selectively active estrogens |
| 08/14/2008 | WO2008095809A1 Nitric oxide releasing steroids |